Skip to main content

Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat

Ocugen said the action is tied to statements made by the World Health Organization following its inspection of Bharat Biotech's manufacturing facility.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.